The Clinical Application of Tauroursodeoxycholic Acid in Patients With Liver Fibrosis.

Summary

This study is a prospective study. We signed an informed consent form with patients with liver fibrosis and took tauroursodeoxycholic acid orally for half a year. After half a year, liver biopsy was performed using histopathology, immunohistochemistry, and polymerase chain reaction, Western blotting method was used to determine the expression level of fibrosis-related markers to verify the effect of taurodeoxycholic acid on patients with liver fibrosis.

Timeline

Start

2021-03-05

Primary completion

2021-07-30

Completion

2021-07-30

Drugs

Indications